NeonMind Biosciences Inc (LCR) AI Stock Analysis

• Market Cap: C$4.16M
• Dividend Yield: N/A
• Average Volume (3M): 290.69K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.40
• Revenue Growth: N/A
• EPS Growth: 2.62%
• Country: CA
• Employees: 28
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Industrial Materials
• EPS (TTM): >-0.01
• Shares Outstanding: 92,499,870
• 10 Day Avg. Volume: 583,757
• 30 Day Avg. Volume: 290,695
• PEG Ratio: <0.01
• Price to Book (P/B): -0.44
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -9.30
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 29 Underperform
• Price Target: ―

NeonMind Biosciences Inc exhibits a challenging financial situation with no revenue, high leverage, and negative cash flows, significantly impacting its overall score. Technical analysis provides some stability signals, but the lack of valuation metrics suggests caution. The overall risk profile suggests a need for strategic changes or additional funding to improve its financial health.

Positive Factors

Innovative Drug Development

NeonMind's focus on developing psychedelic-based therapies positions it at the forefront of innovative mental health treatment, potentially leading to breakthrough products and partnerships with larger pharmaceutical companies.

Potential for Strategic Partnerships

The potential for strategic partnerships with larger pharmaceutical companies could provide significant financial inflows and enhance NeonMind's market presence, aiding in the commercialization of its drug candidates.

Exploration of Wellness Sector

By exploring opportunities in the wellness sector, NeonMind could diversify its revenue streams, reducing dependency on drug development and tapping into a growing market aligned with mental health.

Negative Factors

High Financial Leverage

NeonMind's high financial leverage and negative cash flows indicate a strained financial position, limiting its ability to invest in growth and increasing the risk of financial distress.

Negative Stockholders' Equity

The negative stockholders' equity suggests solvency issues, as liabilities surpass assets, potentially impacting the company's ability to secure additional funding and sustain operations.

Lack of Revenue Generation

The absence of revenue generation underscores operational challenges, hindering NeonMind's ability to achieve profitability and necessitating reliance on external funding to maintain business activities.

NeonMind Biosciences Inc Business Overview & Revenue Model

Company Description

Lancaster Resources Inc. engages in the acquisition, exploration, and development of mineral properties and renewable energy projects. It has option to acquire a 100% interest in the Alkali Flat lithium brine project situated in Lordsburg, New Mexico, the United States. The company is based in West Vancouver, Canada.

How the Company Makes Money

NeonMind Biosciences Inc generates revenue primarily through the development and commercialization of psychedelic-based therapies. The company seeks to advance its drug candidates through clinical trials and secure regulatory approvals, which can lead to partnerships or licensing agreements with larger pharmaceutical companies. These partnerships may provide upfront payments, milestone payments, and royalties on future sales. Additionally, NeonMind may explore opportunities in other sectors such as wellness products or services that align with its core focus on mental health, although specific details on these revenue streams are currently unavailable.

NeonMind Biosciences Inc Financial Statement Overview

Summary

NeonMind Biosciences Inc is facing significant financial challenges, with no current revenue generation, high leverage, and negative cash flows. This suggests a high-risk financial situation with potential liquidity issues and a need for strategic turnaround or additional funding to sustain operations.

Income Statement

NeonMind Biosciences Inc has reported no revenue in the most recent periods, indicating a lack of sales activity or operational revenue. The absence of gross profit, EBIT, and EBITDA suggests ongoing operational losses, while net income figures are unavailable for the latest period, implying a continuation of negative profitability trends seen in past reports.

Balance Sheet

The balance sheet reflects a challenging financial position with negative stockholders' equity, indicating liabilities exceed assets. The company has a high debt load relative to its equity, and negative equity raises solvency concerns, highlighting significant financial risk.

Cash Flow

The cash flow statement shows persistent negative free cash flow and operating cash flow, indicating cash outflows exceed inflows, which could impact liquidity. Financing activities are positive, suggesting reliance on external funding to maintain operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	0.00	0.00	0.00	0.00	0.00	415.80K
Gross Profit	0.00	0.00	0.00	0.00	0.00	415.55K
EBITDA	-1.47M	-897.00	―	-1.75M	-7.83M	-1.06M
Net Income	-1.64M	-1.54M	―	-2.03M	-7.21M	-2.68M
Balance Sheet
Total Assets	818.67K	91.12K	719.33K	129.43K	1.34M	209.90K
Cash, Cash Equivalents and Short-Term Investments	46.00K	13.98K	135.40K	69.91K	967.27K	1.17K
Total Debt	1.12M	1.19M	1.04M	846.94K	450.01K	691.25K
Total Liabilities	1.95M	2.00M	1.33M	1.53M	1.05M	987.31K
Stockholders Equity	-1.12M	-1.90M	-612.89K	-1.40M	290.30K	-777.41K
Cash Flow
Free Cash Flow	-467.75K	-89.79K	-1.31M	-1.22M	-5.82M	-853.45K
Operating Cash Flow	-467.76K	-89.79K	-1.13M	-1.08M	-5.82M	-853.45K
Investing Cash Flow	-28.06K	37.60K	-36.15K	72.14K	389.12K	0.00
Financing Cash Flow	512.86K	0.00	627.93K	271.00K	6.20M	746.93K

NeonMind Biosciences Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LCR, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.90 is Neutral, neither overbought nor oversold. The STOCH value of -11.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LCR.

NeonMind Biosciences Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
PRIZ	52 Neutral	C$12.75M	-2.53	-50.61%	―	―	-3.49%
SCV	44 Neutral	C$1.43M	-0.10	-246.26%	―	―	-70.47%
RAIN	38 Underperform	C$828.26K	-0.60	-68.29%	―	―	3.49%
SASY	33 Underperform	C$665.48K	-0.10	―	―	―	-67.75%
LCR	29 Underperform	C$4.16M	-1.73	―	―	―	2.62%
GCP	29 Underperform	C$5.77M	-8.49	-59.00%	―	―	-122.13%

NeonMind Biosciences Inc Corporate Events

Lancaster Resources Launches Phase 1 Exploration Program at Lake Cargelligo Gold-Silver Project

Lancaster Resources Inc. has outlined its 2026 Phase 1 Exploration and Project Development Program for the Lake Cargelligo Project in New South Wales, designed to advance the site’s district-scale gold and silver potential while also assessing tin and tungsten targets. The work plan includes expanded geological mapping and surface sampling, ground and airborne geophysical surveys, and a roughly 2,500-metre drilling campaign at the Josephine Moulder target to test historical high-grade results and refine resource modelling. By compiling extensive historical assay data, pursuing new drilling and geophysics, and initiating permitting and landowner consultations, Lancaster aims to accelerate its understanding of the scale and grade of mineralization and evaluate potential processing synergies with nearby operating mines, positioning the project for future resource definition and possible faster path to cash flow.

Lancaster Resources Closes Upsized $757,000 Financing for Gold Exploration

Lancaster Resources Inc. has successfully closed a non-brokered private placement financing, raising $757,000, which exceeded the original target of $500,000 due to increased investor interest. The funds will be used for exploration at their Lake Cargelligo Gold Project in Australia, marketing, and general working capital. Notably, insider participation in the financing has led to Penny White holding over 10% of the company’s shares, triggering early-warning reporting requirements.

Lancaster Resources Secures Full Ownership of Lake Cargelligo Gold Project

Lancaster Resources Inc. has completed the title transfer for 100% ownership of the Lake Cargelligo Gold Project in New South Wales, Australia. This project, covering approximately 62,300 hectares, is located in the Cobar mining district and includes historical high-grade gold and silver occurrences. The transfer marks a significant step in Lancaster’s exploration and development activities in Australia, potentially enhancing its industry positioning and offering new opportunities for stakeholders.

Lancaster Resources Upsizes Financing to Accelerate Gold Exploration

Lancaster Resources Inc. has successfully closed a non-brokered private placement financing, raising C$500,000 and upsizing the offering to C$800,000 due to increased investor demand. The funds will be used to advance exploration at the Lake Cargelligo Gold Project in Australia, with the potential for significant gold discoveries, and for general corporate purposes.

Lancaster Resources Expands Exploration Footprint in James Bay

Lancaster Resources Inc. has expanded its exploration footprint in the James Bay region of Quebec by acquiring additional mineral claims at the Lac Iris Polymetallic Project. This acquisition adds approximately 1175 hectares to their existing claims, significantly increasing their land package and reinforcing their position in the polymetallic exploration sector. The strategic location of these claims, near known mineral deposits, enhances Lancaster’s potential for discovering precious and critical metals, aligning with their goal of growing shareholder value.

Lancaster Resources Unveils Promising Gold Targets at Lake Cargelligo

Lancaster Resources Inc., a company engaged in mineral exploration, has announced significant findings from its Lake Cargelligo Gold Project in New South Wales, Australia. The company has identified multiple gold-bearing targets and previously unmapped vein systems through LiDAR and field data analysis, as part of its Phase 1 exploration program. The findings include extensive strike lengths, newly defined targets, and evidence of additional mineralization potential, which could enhance Lancaster’s position in the gold exploration industry. These developments are expected to provide new opportunities for exploration and potential resource expansion, impacting stakeholders positively by potentially increasing the project’s value.

Lancaster Resources Advances Exploration at Lake Cargelligo

Lancaster Resources Inc., a company focused on gold exploration in Australia, has engaged Resource Potentials Pty Ltd to reprocess geophysical data at its Lake Cargelligo Gold Project. This collaboration aims to enhance geological understanding and refine exploration strategies, potentially accelerating the path to drill-ready targets. The project is located in the Lachlan Fold Belt, an area known for high-grade gold and silver occurrences. Additionally, Daniel Kang has resigned from the Board of Directors, and the company is in the process of appointing a new director.

Lancaster Resources Completes Key Technical Report Amid Record Gold Prices

Lancaster Resources Inc. has completed its maiden NI 43-101 Technical Report for the Lake Cargelligo Gold Project in New South Wales, Australia, amid record-high gold prices of $4,300 per ounce. This milestone highlights the project’s strategic importance and potential for significant new gold discoveries, supported by multiple untested targets and a favorable mining jurisdiction. The report, validated by Geos Mining, outlines several mineralization opportunities and recommends a Phase I exploration program to unlock further value for shareholders.